Cargando…

Baseline [(18)F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

BACKGROUND: The role and implementation of tau PET imaging for predicting subsequent cognitive decline in Alzheimer’s disease (AD) remains uncertain. This study was designed to evaluate the relationship between baseline [(18)F]GTP1 tau PET and subsequent longitudinal change across multiple cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Edmond, Manser, Paul T., Sanabria Bohorquez, Sandra, Wildsmith, Kristin R., Pickthorn, Karen, Baker, Suzanne L., Ward, Michael, Kerchner, Geoffrey A., Weimer, Robby M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638526/ https://www.ncbi.nlm.nih.gov/pubmed/34852837 http://dx.doi.org/10.1186/s13195-021-00937-x

Ejemplares similares

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
por: Teng, Edmond, et al.
Publicado: (2022)

CenTauR: Toward a universal scale and masks for standardizing tau imaging studies
por: Villemagne, Victor L., et al.
Publicado: (2023)

Tau Avoids the GTP Cap at Growing Microtubule Plus-Ends
por: Castle, Brian T., et al.
Publicado: (2020)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
por: Ossenkoppele, Rik, et al.
Publicado: (2022)

Cross‐sectional and longitudinal assessments of function in prodromal‐to‐mild Alzheimer's disease: A comparison of the ADCS‐ADL and A‐IADL‐Q scales
por: Teng, Edmond, et al.
Publicado: (2023)

Comprehensive Characterization of (S)GTP-Binding Proteins by Orthogonal Quantitative (S)GTP-Affinity Profiling and (S)GTP/GTP Competition Assays
por: Xiao, Yongsheng, et al.
Publicado: (2014)

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
por: Cicognola, Claudia, et al.
Publicado: (2018)

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease
por: Hunt, Aoife, et al.
Publicado: (2006)

Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
por: Bucci, Marco, et al.
Publicado: (2021)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data
por: Baker, Suzanne L., et al.
Publicado: (2017)

Optimizing quantification of MK6240 tau PET in unimpaired older adults
por: Harrison, Theresa M., et al.
Publicado: (2023)

Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment
por: Chen, Charles D., et al.
Publicado: (2023)

FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer’s Disease
por: Jann, Kay, et al.
Publicado: (2023)

An intermolecular G-quadruplex as the basis for GTP recognition in the class V–GTP aptamer
por: Nasiri, Amir H., et al.
Publicado: (2016)

The speed of GTP hydrolysis determines GTP cap size and controls microtubule stability
por: Roostalu, Johanna, et al.
Publicado: (2020)

Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults
por: Pereira, Joana B., et al.
Publicado: (2020)

Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
por: Biel, Davina, et al.
Publicado: (2021)

Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease
por: Biel, Davina, et al.
Publicado: (2022)

Evaluation of a visual interpretation method for tau‐PET with (18)F‐flortaucipir
por: Sonni, Ida, et al.
Publicado: (2020)

A GTP signal to the nucleolus
por: Tuma, Rbiya S.
Publicado: (2005)

Going in GTP cycles in the nucleolus
por: Misteli, Tom
Publicado: (2005)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
por: DeFelipe, Javier
Publicado: (2016)

Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
por: Bussian, Tyler J., et al.
Publicado: (2018)

Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB
por: Jamalian, Samira, et al.
Publicado: (2023)

Induction of Ran GTP drives ciliogenesis
por: Fan, Shuling, et al.
Publicado: (2011)

Reconstitution of microtubule into GTP-responsive nanocapsules
por: Uchida, Noriyuki, et al.
Publicado: (2022)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Blue News Update: BODIPY-GTP Binds to the Blue-Light Receptor YtvA While GTP Does Not
por: Dorn, Matthias, et al.
Publicado: (2012)

Crystal Structure of Transglutaminase 2 with GTP Complex and Amino Acid Sequence Evidence of Evolution of GTP Binding Site
por: Jang, Tae-Ho, et al.
Publicado: (2014)

Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition
por: Rauchmann, Boris Stephan, et al.
Publicado: (2021)

The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis
por: Lewandowska, Katarzyna B., et al.
Publicado: (2023)

Serotonergic system in vivo with [(11)C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients
por: Timmers, Elze R., et al.
Publicado: (2022)

An Automated Method to Quantify Microglia Morphology and Application to Monitor Activation State Longitudinally In Vivo
por: Kozlowski, Cleopatra, et al.
Publicado: (2012)

Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
por: Monteiro, Cecilia, et al.
Publicado: (2023)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020)

LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
por: Taymans, Jean-Marc, et al.
Publicado: (2011)

Citrate Regulates the Saccharomyces cerevisiae Mitochondrial GDP/GTP Carrier (Ggc1p) by Triggering Unidirectional Transport of GTP
por: Seccia, Roberta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1sng649o70v6q98kt5i0r0fsis